D. Montani (Le Kremlin-Bicêtre, France), F. De Man (Amsterdam, Netherlands), S. Savai Pullamsetti (Bad Nauheim, Germany), C. Guignabert (Paris, France)
Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS).
S. Esquivel-Ruiz (Madrid, Spain), B. Barreira (Madrid, Spain), M. Alvárez-Fuente (Madrid, Spain), A. Gurjian (Madrid, Spain), P. Hernández-Hernández (Madrid, Spain), Á. González-Murillo (Madrid, Spain), M. Ramírez-Orellana (Madrid, Spain), M. Del Cerro (Madrid, Spain), Á. Cogolludo (Madrid, Spain), F. Pérez-Vizcaíno (Madrid, Spain), L. Moreno (Madrid, Spain)
|  |
Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
C. Eichstaedt (Heidelberg, Germany), H. Mairbäurl (Heidelberg, Germany), J. Song (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Fischer (Heidelberg, Germany), K. Hinderhofer (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)
| |
BMPR2 mRNA functioning as competing endogenous RNA in pulmonary arterial hypertension associated with systemic-to-pulmonary shunts
K. Ma (Beijing, China), L. Qi (Beijing, China), H. Zhang (Beijing, China), S. Zhang (Beijing, China), F. He (Beijing, China), G. Wang (Beijing, China), Z. Feng (Beijing, China), S. Li (Beijing, China)
| |
Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH).
J. Abu-Hanna (London, United Kingdom), J. Taanman (London, United Kingdom), D. Abraham (London, United Kingdom), L. Clapp (London, United Kingdom)
| |
Gene-Gene Interaction between EPAS1 and EGLN1 in Patients with High-Altitude Pulmonary Edema
T. Horiuchi (Matsumoto, Japan), Y. Droma (Matsumoto, Japan), F. Kinota (Matsumoto, Japan), N. Kobayashi (Matsumoto, Japan), M. Ota (Matsumoto, Japan), M. Hanaoka (Matsumoto, Japan)
| |
Kv1.5 channels and endothelium-dependent relaxation are downregulated by miR-1 in rat pulmonary arteries.
G. Mondejar Parreño (Madrid, Spain), M. Callejo (Madrid, Spain), B. Barreira (Madrid, Spain), D. Morales-Cano (Madrid, Spain), L. Moreno (Madrid, Spain), S. Esquivel-Ruiz (Madrid, Spain), A. Cogolludo (Madrid, Spain), F. Perez-Vizcaino (Madrid, Spain)
| |
Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension
S. Pedersen (LONDON, United Kingdom), Q. Toe (LONDON, United Kingdom), S. Wort (LONDON, United Kingdom), G. Quinlan* (LONDON, United Kingdom), L. Ramakrishnan* (LONDON, United Kingdom)
|  |
Activation of the Beta-3 adrenoceptor in experimental pulmonary hypertension
P. Mendes Ferreira (Leuven, Belgium), R. Adao (Porto, Portugal), R. Quarck (Leuven, Belgium), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium), C. Bras-Silva (Porto, Portugal)
| |
Pulmonary Hypertension in Female Rats: Estrogens and Age Influence
A. Obeso (Valladolid, Spain), E. Olea (Valladolid, Spain), A. Rocher (Valladolid, Spain), A. Gordillo (Valladolid, Spain), A. Gomez-Niño (Valladolid, Spain), J. Prieto-Lloret (Valladolid, Spain)
| |
Leukotriene-mediated sex dimorphism in pulmonary arterial hypertensionmonocrotaline-induced rat.
A. Liparulo (Naples, Italy), G. Spaziano (Naples, Italy), T. Russo (Naples, Italy), A. Rossi (Naples, Italy), F. Roviezzo (Naples, Italy), R. Filosa (Naples, Italy), M. Sgambato (Naples, Italy), G. Tartaglione (Naples, Italy), R. Esposito (Naples, Italy), B. D'Agostino (Naples, Italy)
| |
Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension
A. Parpaleix (Creteil, France), S. Abid (Creteil, France), E. Marcos (Creteil, France), V. Amsellem (Creteil, France), A. Houssaïni (Creteil, France), M. Breau (Creteil, France), D. Sawaki (Creteil, France), E. Bizard (Creteil, France), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), L. Lipskaia (Creteil, France), S. Adnot (Creteil, France)
| |
Effect of BMPRII on endothelial function in human lung microvascular endothelial cells
B. Tielemans (Leuven, Belgium), R. Gijsbers (Leuven, Belgium), A. Michiels (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), R. Farre Marti (Leuven, Belgium), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium)
| |
Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV
J. Sandoval Gutierrez (Mexico city, Mexico), R. Rivera Morales (Mexico city, Mexico), J. Rodriguez Silverio (Mexico city, Mexico)
| |
Cold exposure lowered miR-21-5p expression in monocrotaline induced pulmonary artery hypertension.
J. Sánchez (Mexico City, Mexico), R. Carbó (Mexico City, Mexico), A. Hernández (Mexico City, Mexico), R. Bojalil (Mexico City, Mexico), F. Sánchez (Mexico City, Mexico), J. Sandoval (Mexico City, Mexico), F. Sánchez (Mexico City, Mexico)
| |
Maladaptive Pulmonary vascular responses to chronic intermittent and sustained hypoxia in a rat hypertension model
A. Rocher (Valladolid, Spain), J. Prieto-Lloret (Valladolid, Spain), I. Docio (Valladolid, Spain), E. Olea (Valladolid, Spain), M. Bravo (Valladolid, Spain), A. Obeso (Valladolid, Spain), A. Gomez-Niño (Valladolid, Spain)
| |
The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension
X. Sun (Amsterdam, Netherlands), E. Peters (Amsterdam, Netherlands), I. Schalij (Amsterdam, Netherlands), S. Andersen (Aarhus, Denmark), D. Da Silva Goncalves Bos (Amsterdam, Netherlands), A. Vonk-Noordegraaf (Amsterdam, Netherlands), F. S De Man (Amsterdam, Netherlands), W. Van Der Laarse (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands)
| |
Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension
S. Cantoni (Parma, Italy), S. Cavalli (Parma, Italy), F. Pastore (Parma, Italy), R. Nassini (Florence, Italy), F. De Logu (Florence, Italy), G. Villetti (Parma, Italy), F. Facchinetti (Parma, Italy)
| |
Effects of acute increases in right ventricular preload and afterload on pulmonary artery pulse pressure in a chronic thromboembolic hypertension model
D. Boulate (Le Plessis-Robinson, France), D. Chemla (Le Kremlin-Bicêtre, France), F. Loisel (Le Plessis-Robinson, France), B. Decante (Le Plessis-Robinson, France), P. Herve (Le Plessis-Robinson, France), F. Haddad (Palo Alto, CA, United States of America), E. Fadel (Le Plessis-Robinson, France), O. Mercier (Le Plessis-Robinson, France)
| |
Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model
D. Boulate (Le Plessis-Robinson, France), D. Chemla (Le Kremlin-Bicêtre, France), F. Loisel (Le Plessis-Robinson, France), M. Coblence (Le Plessis-Robinson, France), B. Provost (Le Plessis-Robinson, France), B. Decante (Le Plessis-Robinson, France), P. Herve (Le Plessis-Robinson, France), E. Fadel (Le Plessis-Robinson, France), O. Mercier (Le Plessis-Robinson, France)
| |